NDC 82922-040 - Truemed Group LLC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 82922-040
- Package NDCs from labels
- 82922-040-02
- Manufacturer
- Truemed Group LLC
- Effective date
- 2022-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MEDROXYPROGESTERONE ACETATE ESTRADIOL CYPIONATE - Truemed Group LLC | Truemed Group LLC | 2022-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | bfdf335d-1cbb-4533-9fde-99a9c71f7504 | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 788df737-e990-4b5e-accd-af13c3b2bf8b | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Amneal Pharmaceuticals NY LLC | a80560e1-96dd-4380-b3e1-d52719ccdd4b | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Coupler LLC | 2cf48919-6de8-d3d0-e063-6394a90ac1bc | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate Injectable Suspension | MEDROXYPROGESTERONE ACETATE | Hikma Pharmaceuticals USA Inc. | 0476eac5-d96c-4910-aa86-1ddeeefefe50 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 437edd12-2c08-4df4-8cf7-64c47e4779ac | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | a36c89b7-9463-4d00-a4d3-021d77090077 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | bdb89690-ced2-48e1-bb1a-e5eccfeda8eb | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | NuCare Pharmaceuticals,Inc. | 5c8ffae3-3b3e-197e-e053-2a91aa0a59e3 | 2024-06-04 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Teva Pharmaceuticals USA, Inc. | 9eb200b0-db96-4a51-87ea-04db862978c8 | 2024-03-01 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Depo-Estradiol | ESTRADIOL CYPIONATE | Pharmacia & Upjohn Company LLC | 9a4229fd-fecd-4ac1-9c4f-6d442533457f | 2024-02-28 | Boxed warning, Warnings, Adverse reactions | 7E1DV054LO |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | ca344c55-5251-470f-9243-eceb9e496e3e | 2023-10-23 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Proficient Rx LP | 0df6fd1e-7d9c-4a38-848c-1e562e211c91 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Sun Pharmaceutical Industries, Inc. | 01e28bef-9758-40cf-a4ff-86ae9f4f5105 | 2022-12-14 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| ed8b4e3d-b8d7-e390-e053-2995a90a660a | e5fccda4-f115-4e80-e053-2a95a90a46b2 | 2022-11-15 | e5fccda4-f115-4e80-e053-2a95a90a46b2 | |||
| Medroxyprogesterone | MEDROXYPROGESTERONE | PharmPak, Inc. | 1403a9a9-c04a-432f-8819-4850f779312e | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Sun Pharmaceutical Industries, Inc. | d1ea4098-6196-421f-b8e1-bcb31a061e04 | 2021-06-29 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Mylan Institutional LLC | 60aba812-59eb-4d40-9b6b-d135dca9d36b | 2021-03-12 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.